Krystal Biotech buy Chardan Capital
Start price
18.12.24
/
50%
€151.90
Target price
18.12.25
€202.14
Performance (%)
37.33%
Price
22:26
€208.60
This prediction will end soon
Summary
This prediction is currently active. With a performance of 37.33% the BUY prediction by Chardan_Capital is a big success. This prediction currently runs until 18.12.25. The prediction end date can be changed by Chardan_Capital at any time. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Krystal Biotech | 10.231% | 10.231% |
| iShares Core DAX® | 2.018% | 0.724% |
| iShares Nasdaq 100 | -0.476% | -0.744% |
| iShares Nikkei 225® | -0.675% | -2.884% |
| iShares S&P 500 | -0.163% | -0.442% |
Comments by Chardan_Capital for this prediction
In the thread Krystal Biotech diskutieren
Krystal Biotech, Inc. (NASDAQ: KRYS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $212.00 price target on the stock.
Ratings data for KRYS provided by MarketBeat